KDR and pulmonary arterial hypertension: To seek further evidence for KDR as a new candidate gene for PAH, we analyzed subjects recruited to the US PAH Biobank12 and the Columbia University Irving Medical Center14 to identify additional patients carrying predicted pathogenic rare variants.